EUVIMEDEUVIMED entdecken
Crossref

Factor VIIa–Antithrombin Complexes are Increased in Asthma: Relation to the Exacerbation-Prone Asthma Phenotype

Stanislawa Bazan-Socha iD, Lucyna Mastalerz, Agnieszka Cybulska, Lech Zareba, Bogdan Jakiela, Michal Zabczyk iD, Teresa Iwaniec, Anetta Undas

Thrombosis and Haemostasis · 2026-01 · 126 (01) · 037-048

DOI: 10.1055/a-2515-1402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thrombosis and Haemostasis, online erschienen am 31.01.2025. Verfasst von Stanislawa Bazan-Socha und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland. Hauptthemen laut MEDLINE: Asthma, Factor VIIa, Antithrombin III, Peptide Hydrolases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Narodowe Centrum Nauki.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Asthma is associated with a prothrombotic state. Plasma factor VIIa–antithrombin complex (FVIIa-AT) concentrations indirectly reflect the interaction of tissue factor (TF) with FVII. Since TF is a key initiator of coagulation in vivo, we hypothesized that FVIIa-AT concentrations are higher in asthma. In 159 clinically stable adult asthma patients and 62 controls, we determined FVIIa-AT in plasma and analyzed their relation to circulating inflammatory and prothrombotic markers together with the total plasma potential for fibrinolysis (clot lysis time, CLT) and thrombin generation. We recorded clinical outcomes, including asthma exacerbations, during 3-year follow-up. Asthma patients were characterized by 38.5% higher FVIIa-AT (p < 0.001), related to bronchial obstruction (FEV1: r = −0.397, p < 0.001), asthma severity (r = 0.221, p = 0.005), and duration (r = 0.194, p = 0.015) compared to controls. FVIIa-AT showed weak positive associations with C-reactive protein (r = 0.208, p = 0.009), fibrinogen (r = 0.215, p = 0.007), and CLT (r = 0.303, p < 0.001) but not with thrombin generation parameters. In the follow-up (data obtained from 151 patients), we documented 151 severe asthma exacerbations in 51 (33.8%) patients, including 33 (21.9%) with ≥2 such events. Exacerbation-prone asthma phenotype was related to 13.1% higher FVIIa-AT (p = 0.012), along with asthma severity and control (p < 0.003, both). High FVIIa-AT (that is ≥100.1 pmol/L), defined on receiver operating characteristic curves, was linked to exacerbation-prone asthma phenotype (odds ratio 1.85; 95%CI: 1.23–2.80, p = 0.003) and shorter time to first exacerbation (p = 0.023). This study is the first to show that FVIIa-AT concentrations are higher in asthma in relation to its severity and may help identify individuals at risk of the exacerbation-prone asthma phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaFactor VIIaAntithrombin IIIPeptide HydrolasesHumansMaleFemaleMiddle AgedAdultPhenotypeBiomarkersCase-Control StudiesDisease ProgressionThrombinFibrinolysisSeverity of Illness IndexAgedBlood CoagulationUp-Regulation

Substanzen

Factor VIIaBiomarkersThrombinAntithrombin IIIPeptide Hydrolases

Autor:innen und Institutionen

  • Department of Internal Medicine, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.
  • College of Natural Sciences, Institute of Computer Science, University of Rzeszow, Rzeszów, Poland.
  • Department of Thromboembolic Diseases, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland.
  • Department of Hematology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.
  • Centre for Medical Research and Technologies, The St. John Paul II Hospital, Krakow, Poland.

ORCID-Profile: Stanislawa Bazan-Socha, Michal Zabczyk

Förderung

  • Narodowe Centrum Nauki

Zitieren

APA

Bazan-Socha, S., Mastalerz, L., Cybulska, A., Zareba, L., Jakiela, B., Zabczyk, M., Iwaniec, T., & Undas, A. (2026). Factor VIIa–Antithrombin Complexes are Increased in Asthma: Relation to the Exacerbation-Prone Asthma Phenotype. Thrombosis and Haemostasis, 126(01), 037-048. https://doi.org/10.1055/a-2515-1402

Vancouver

Bazan-Socha S, Mastalerz L, Cybulska A, Zareba L, Jakiela B, Zabczyk M, et al. Factor VIIa–Antithrombin Complexes are Increased in Asthma: Relation to the Exacerbation-Prone Asthma Phenotype. Thrombosis and Haemostasis. 2026;126(01):037-048. doi:10.1055/a-2515-1402

BibTeX
@article{BazanSocha2026,
  author = {Bazan-Socha, Stanislawa and Mastalerz, Lucyna and Cybulska, Agnieszka and Zareba, Lech and Jakiela, Bogdan and Zabczyk, Michal and Iwaniec, Teresa and Undas, Anetta},
  title = {Factor VIIa–Antithrombin Complexes are Increased in Asthma: Relation to the Exacerbation-Prone Asthma Phenotype},
  journal = {Thrombosis and Haemostasis},
  year = {2026},
  volume = {126},
  number = {01},
  pages = {037--048},
  doi = {10.1055/a-2515-1402}
}
Kostenlos starten →